Exscientia Plc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Exscientia Plc (EXAI) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Exscientia Plc vs Its Competitors
- TTM: Trailing 12-month revenue of 25M vs 261M combined for tracked competitors (8.7% combined share).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
Exscientia Plc vs. its Competitors, Q4 2021
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Exscientia Plc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Exscientia Plc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (2) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Exscientia Plc's competitor groups requires a Commercial License.
Exscientia Plc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Exscientia Plc | - | - | - | - |
| Competitors combined (2) | ||||
| High-Confidence Competitors (3) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
EXAI Stock Performance relative to its Competitors
EXAI Stock Performance relative to High-Confidence Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Absci Corp | 282.9% | Outperformed |
| 2 | Schrodinger Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Exscientia Plc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Exscientia Plc's Comment on Competition and Industry Peers
Publicly Traded Peers of Exscientia Plc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Exscientia Plc | 601.11 | 24.98 |
| Schrodinger Inc | 2,352.64 | 259.03 |
| Absci Corp | 1,695.97 | 1.56 |
| SUBTOTAL | 4,649.72 | 285.57 |
Sources: Exscientia Plc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Exscientia Plc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Exscientia Plc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Absci Corp | Named by the company | 85% |
| BMS | Named by the company | 85% |
| Bristol Myers Squibb | Named by the company | 85% |
| Schrodinger Inc | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Exscientia Plc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Exscientia Plc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Schrodinger Inc | Software 60.70 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Exscientia Plc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Exscientia Plc | 601 | - | - |
| Schrodinger Inc | 2,353 | 304,747 | -63,924 |
| Absci Corp | 1,696 | 11,150 | -864,836 |
| PEERS TOTAL | 4,049 | 263,228 | -177,184 |
Exscientia Plc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Schrodinger Inc | United States 53.61 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Exscientia Plc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
No rule matched.
Opportunities
- Industry revenue growing at a healthy 10.0% median pace.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-26.9% annualized).
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Exscientia Plc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Exscientia Plc | 3.99 | 6.22 | - |
| Schrodinger Inc | 1.40 | 2.84 | - |
| Absci Corp | 1.59 | 7.22 | 0.00 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Exscientia Plc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Exscientia Plc | Q4 2021 | -25.8 % | - |
| Schrodinger Inc | Q2 2026 | +7.5 % | - |
| Absci Corp | Q2 2026 | -46.4 % | - |
| PEERS TOTAL | -5.4 % | - |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Exscientia Plc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Exscientia Plc | Q4 2021 | -17.2 % | +18.8 % |
| Schrodinger Inc | Q2 2026 | -7.5 % | +15.3 % |
| Absci Corp | Q2 2026 | - | -99.6 % |
Exscientia Plc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Exscientia Plc | - | - | - |
| Schrodinger Inc | - | - | - |
| Absci Corp | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Exscientia Plc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Exscientia Plc | - | 24.07 |
| Schrodinger Inc | - | 9.08 |
| Absci Corp | - | 1,086.46 |
| PEERS AVERAGE | - | 16.28 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.